Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3074% above fair value
$320.60+1.49 (+0.47%)
Close on Nov 18, 2026Market cap $12.64BP/E 80.8Yield –
Penumbra shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Penumbra's shares outstanding was 40M at Sep 30, 2026. For fiscal 2025 it was 39M, up 0.1% from the year before. Over ten years it grew 10.7% a year on average. The highest annual figure on record is 39M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 39M | +0.1% |
| FY2024 | Dec 31, 2024 | 39M | +0.1% |
| FY2023 | Dec 31, 2023 | 39M | +3.6% |
| FY2022 | Dec 31, 2022 | 38M | -0.1% |
| FY2021 | Dec 31, 2021 | 38M | +5.9% |
| FY2020 | Dec 31, 2020 | 36M | -1.4% |
| FY2019 | Dec 31, 2019 | 36M | +0.5% |
| FY2018 | Dec 31, 2018 | 36M | +2.2% |
| FY2017 | Dec 31, 2017 | 35M | +5.5% |
| FY2016 | Dec 31, 2016 | 33M | +135.4% |
| FY2015 | Dec 31, 2015 | 14M | +208.5% |
| FY2014 | Dec 31, 2014 | 5M | -29.1% |
| FY2013 | Dec 31, 2013 | 7M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 40M | +0.8% |
| Q2 FY2026 | Jun 30, 2026 | 40M | +0.8% |
| Q1 FY2026 | Mar 31, 2026 | 40M | +1.0% |
| Q4 FY2025 | Dec 31, 2025 | 39M | -3.8% |
| Q3 FY2025 | Sep 30, 2025 | 39M | +0.3% |
| Q2 FY2025 | Jun 30, 2025 | 39M | +1.2% |
| Q1 FY2025 | Mar 31, 2025 | 39M | -0.6% |
| Q4 FY2024 | Dec 31, 2024 | 41M | +4.2% |
| Q3 FY2024 | Sep 30, 2024 | 39M | -0.1% |
| Q2 FY2024 | Jun 30, 2024 | 39M | -1.0% |
| Q1 FY2024 | Mar 31, 2024 | 39M | +0.8% |
| Q4 FY2023 | Dec 31, 2023 | 39M | +1.0% |
| Q3 FY2023 | Sep 30, 2023 | 39M | +3.4% |
| Q2 FY2023 | Jun 30, 2023 | 39M | +3.8% |
| Q1 FY2023 | Mar 31, 2023 | 39M | +0.9% |
| Q4 FY2022 | Dec 31, 2022 | 39M | +3.9% |
| Q3 FY2022 | Sep 30, 2022 | 38M | +0.8% |
| Q2 FY2022 | Jun 30, 2022 | 38M | +0.5% |
| Q1 FY2022 | Mar 31, 2022 | 39M | +3.1% |
| Q4 FY2021 | Dec 31, 2021 | 37M | -0.0% |
| Q3 FY2021 | Sep 30, 2021 | 38M | +3.9% |
| Q2 FY2021 | Jun 30, 2021 | 38M | +6.2% |
| Q1 FY2021 | Mar 31, 2021 | 38M | +3.2% |
| Q4 FY2020 | Dec 31, 2020 | 37M | +3.1% |
| Q3 FY2020 | Sep 30, 2020 | 36M | -0.2% |
| Q2 FY2020 | Jun 30, 2020 | 35M | -2.2% |
| Q1 FY2020 | Mar 31, 2020 | 36M | +0.4% |
| Q4 FY2019 | Dec 31, 2019 | 36M | +0.4% |
| Q3 FY2019 | Sep 30, 2019 | 36M | +5.9% |
| Q2 FY2019 | Jun 30, 2019 | 36M | +0.3% |
| Q1 FY2019 | Mar 31, 2019 | 36M | +0.8% |
| Q4 FY2018 | Dec 31, 2018 | 36M | +0.9% |
| Q3 FY2018 | Sep 30, 2018 | 34M | -4.0% |
| Q2 FY2018 | Jun 30, 2018 | 36M | +8.7% |
| Q1 FY2018 | Mar 31, 2018 | 36M | +13.6% |
| Q4 FY2017 | Dec 31, 2017 | 36M | +15.4% |
| Q3 FY2017 | Sep 30, 2017 | 36M | – |
| Q2 FY2017 | Jun 30, 2017 | 33M | – |
| Q1 FY2017 | Mar 31, 2017 | 32M | – |
| Q4 FY2016 | Dec 31, 2016 | 31M | – |
See a number that looks wrong?